JNJ vs GILD
By Alex · Tickerpine
Johnson & Johnson vs Gilead Sciences, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | GILD |
|---|---|---|
| Price | $273.14 | $148.77 |
| Market cap | $658.24B | $184.47B |
| P/E ratio | 31.7 | — |
| ROE | 25.74% | -20.68% |
| Profit margin | 21.48% | -10.64% |
| Revenue growth | 6.60% | 10.20% |
| Dividend yield | 1.96% | 2.20% |
| Beta | 0.23 | 0.34 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs GILD in plain English
- JNJ is the bigger company — about 3.6× the market cap of GILD.
- JNJ earns a higher return on equity (26% vs -21%).
- GILD is growing revenue faster (10% vs 7%).
- GILD has the higher dividend yield (2.20% vs 1.96%).
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
GILD return calculator
See what $1,000 in Gilead Sciences, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.